IMVT
Immunovant Inc

2,215
Mkt Cap
$5.04B
Volume
1.04M
52W High
$29.25
52W Low
$12.72
PE Ratio
-9.23
IMVT Fundamentals
Price
$25.36
Prev Close
$24.76
Open
$24.35
50D MA
$26.00
Beta
1.07
Avg. Volume
1.38M
EPS (Annual)
-$2.73
P/B
5.10
Rev/Employee
$0.00
$1,876.52
Loading...
Loading...
News
all
press releases
Tuyl Christopher Van Sells 2,877 Shares of Immunovant (NASDAQ:IMVT) Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) insider Tuyl Christopher Van sold 2,877 shares of the business's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $24.97, for a total transaction of $71,838.69. Following the completion of the transaction...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Immunovant (NASDAQ:IMVT) Insider Tuyl Christopher Van Sells 2,877 Shares
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) insider Tuyl Christopher Van sold 2,877 shares of the firm's stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $24.97, for a total transaction of $71,838.69. Following the completion of the sale, the...
MarketBeat·6d ago
News Placeholder
Immunovant (NASDAQ:IMVT) Now Covered by Sanford C. Bernstein
Sanford C. Bernstein assumed coverage on shares of Immunovant in a research note on Friday. They issued a "market perform" rating and a $28.00 target price on the stock...
MarketBeat·6d ago
News Placeholder
Immunovant, Inc. $IMVT is Alpine Global Management LLC's 3rd Largest Position
Alpine Global Management LLC increased its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 4.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·9d ago
News Placeholder
Immunovant, Inc. $IMVT Shares Purchased by Granahan Investment Management LLC
Granahan Investment Management LLC boosted its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 24.9% in the third quarter, according to the company in its most recent Form 13F...
MarketBeat·9d ago
News Placeholder
HighVista Strategies LLC Grows Position in Immunovant, Inc. $IMVT
HighVista Strategies LLC increased its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 38.5% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·10d ago
News Placeholder
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?
Key PointsLogos added 1.1 million shares of Immunovant last quarter, a purchase estimated at about $24.5 million based on quarterly average pricing...
Nasdaq News: Markets·11d ago
News Placeholder
Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Moderate Buy" by Analysts
Shares of Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) have received a consensus rating of "Moderate Buy" from the ten ratings firms that are currently covering the stock, MarketBeat reports. One...
MarketBeat·12d ago
News Placeholder
Immunovant Stock Up 30% as Investor Trims Stake by $3 Million, But Here's Why It Still Seems Bullish
Key PointsAlpine Global Management sold 128,039 shares of Immunovant in the fourth quarter; the estimated transaction value was $2.8 million based on quarterly average prices...
Nasdaq News: Markets·15d ago
News Placeholder
Immunovant Stock Surges 17% in 3 Months: What's Driving It?
IMVT gains 17% in three months as IMVT-1402 advances across autoimmune trials, with multiple data readouts due in 2026-2027, and $994.5M cash backing development.
Zacks·21d ago
<
1
2
...
>

Latest IMVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.